Circulating miRNAs Signature as a Predictor of Cachexia in Chronic Heart Failure: Diagnostic and Prognostic Implications
- 1Department of Human Physiology of the Chair of Preclinical Sciences, Medical University in Lublin, Radziwillowska 11 street, 20-080, Lublin, Poland. tomaszpowrozek@gmail.com.
- 2Department of Human Physiology of the Chair of Preclinical Sciences, Medical University in Lublin, Radziwillowska 11 street, 20-080, Lublin, Poland.
- 3Department of Cardiology, 1 st Military Clinical Hospital with the Outpatient Clinic, Lublin, Poland.
- 4Med Biotech Hub and Competence Center, Department of Medical Biotechnologies, University of Siena, Siena, Italy.
- 5Cancer Genomics and Systems Biology Lab, Department of Medical Biotechnologies, University of Siena, Siena, Italy.
- 0Department of Human Physiology of the Chair of Preclinical Sciences, Medical University in Lublin, Radziwillowska 11 street, 20-080, Lublin, Poland. tomaszpowrozek@gmail.com.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.New biomarkers for cachexia in chronic heart failure (CHF) have been identified. A specific microRNA (miRNA) signature accurately predicts cachexia risk and poor survival in CHF patients.
Area Of Science
- Biochemistry
- Genomics
- Cardiology
Background
- Cachexia significantly worsens outcomes and survival in chronic heart failure (CHF) patients.
- Early detection of cachexia is critical for improving patient prognosis.
- Circulating microRNAs (miRNAs) are promising biomarkers linking cardiac function, inflammation, and cachexia.
Purpose Of The Study
- To identify plasma miRNAs associated with cachexia in CHF patients.
- To evaluate the diagnostic and prognostic value of identified miRNAs.
- To explore the potential of miRNAs as biomarkers for nutritional status in CHF.
Main Methods
- Plasma samples from 150 newly diagnosed CHF patients were analyzed.
- Next-generation sequencing (NGS) was used for initial miRNA identification.
- Quantitative reverse transcription polymerase chain reaction (qRT-PCR) was employed for validation.
Main Results
- A distinct miRNA signature (elevated miRNA-628 and reduced miRNA-6803) was identified and associated with cachexia.
- This signature, combined with inflammatory markers, perfectly distinguished cachectic from non-cachectic patients (AUC=1.0).
- The miRNA profile significantly increased cachexia risk (19-fold) and was linked to shorter survival (14 vs. 41 months).
Conclusions
- The identified miRNA signature demonstrates strong diagnostic and predictive potential for cachexia in CHF.
- This miRNA profile can complement clinical assessments of nutritional status in CHF patients.
- Circulating miRNAs offer a valuable tool for early detection and risk stratification of cachexia in heart failure.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.

